Cargando…
Pioglitazone and sulfonylureas: effectively treating type 2 diabetes
Type 2 diabetes is characterised by a gradual decline in glycaemic control and progression from oral glucose-lowering monotherapy to combination therapy and exogenous insulin therapy. Functional decline of the insulin-secreting β-cells is largely responsible for the deterioration in glycaemic contro...
| Autor principal: | |
|---|---|
| Formato: | Texto |
| Lenguaje: | English |
| Publicado: |
Blackwell Publishing Ltd
2007
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1974826/ https://www.ncbi.nlm.nih.gov/pubmed/17594390 http://dx.doi.org/10.1111/j.1742-1241.2007.01361.x |